-

Ajay Dhankhar Joins Lazard as a Managing Director in Healthcare Group, Financial Advisory

NEW YORK--(BUSINESS WIRE)--Lazard Ltd (NYSE: LAZ) announced today that Ajay Dhankhar has joined the firm as a Managing Director in the Healthcare Group within Financial Advisory, effective immediately. Based in New York, Mr. Dhankhar will serve as Global Head of Medical Technology, Diagnostics and Tools. He will also advise clients in other healthcare segments, including biopharmaceuticals, and healthcare information and technology.

“Ajay brings deep experience to our Healthcare practice as a trusted strategic advisor to C-suite executives and boards,” said David Gluckman, Global Head of the Healthcare Group at Lazard. “The healthcare sector, including medical devices and technology, is experiencing strong growth that is set to continue in the years ahead. Adding a seasoned healthcare advisor like Ajay will ensure Lazard continues to provide clients with the very best possible advice.”

Mr. Dhankhar is a former biochemist and a highly experienced healthcare advisor, with particular expertise in the fields of medical technology, diagnostics and tools, and biopharmaceuticals. He is an established thought leader, espousing the concept that portfolio optimization through M&A, joint ventures and divestments, when coupled with rational capital allocation, can help companies deliver sector- and industry-leading shareholder value.

Mr. Dhankhar has advised on more than 50 major transactions, including four of the 10 largest mergers and/or restructurings to have taken place in the life sciences industry in recent years. He joins Lazard from McKinsey & Company, where he was a Senior Partner and Global Leader of the firm’s Life Sciences Strategy, M&A, Corporate Finance and Enterprise Risk practices. He previously served as Global Leader of McKinsey’s Life Sciences R&D practice.

Mr. Dhankhar has a bachelor’s degree in Physics and Computer Science from Angelo State University and both a master’s degree and a doctorate in Molecular Biophysics and Biochemistry from Yale University.

About Lazard
Lazard, one of the world's preeminent financial advisory and asset management firms, operates from 40 cities across 25 countries in North and South America, Europe, Asia and Australia. With origins dating to 1848, the firm provides advice on mergers and acquisitions, strategic matters, restructuring and capital structure, capital raising and corporate finance, as well as asset management services to corporations, partnerships, institutions, governments and individuals. For more information on Lazard, please visit www.lazard.com. Follow Lazard at @Lazard

LAZ_FAPE 

Contacts

Media Contact:
Judi Frost Mackey, +1 212 632 1428
judi.mackey@lazard.com

Investor Contact:
Alexandra Deignan, +1 212 632 6886
alexandra.deignan@lazard.com

Lazard Ltd

NYSE:LAZ

Release Versions

Contacts

Media Contact:
Judi Frost Mackey, +1 212 632 1428
judi.mackey@lazard.com

Investor Contact:
Alexandra Deignan, +1 212 632 6886
alexandra.deignan@lazard.com

More News From Lazard Ltd

Lazard Bolsters Global Industrials Practice by Adding Three New Managing Directors

NEW YORK--(BUSINESS WIRE)--Lazard, Inc. (NYSE: LAZ), the preeminent global financial advisory and asset management firm, announced today the appointments of Bill Young, Jean Greene, and Paolo Battaglia as Managing Directors in the firm’s Global Industrials Group, all based in New York. These appointments further strengthen Lazard’s market-leading global Industrials franchise, which advises clients across diversified industrials, building products, chemicals, paper & packaging, transportatio...

Lazard CEO and Chairman Peter R. Orszag to Speak at the 2025 Goldman Sachs U.S. Financial Services Conference

NEW YORK--(BUSINESS WIRE)--Lazard, Inc. (NYSE: LAZ) today announced Peter R. Orszag, CEO and Chairman, is scheduled to participate in a fireside discussion at the Goldman Sachs U.S. Financial Services Conference on Wednesday, December 10, at 10:00 a.m. E.T. A live audio webcast will be available via the Lazard Investor Relations website at www.lazard.com. A replay will be available on the same website, shortly after the conference. About Lazard Founded in 1848, Lazard is the preeminent financia...

Lazard Reports October 2025 Assets Under Management

NEW YORK--(BUSINESS WIRE)--Lazard, Inc. (NYSE: LAZ) reported today that its preliminary assets under management (“AUM”) as of October 31, 2025 totaled approximately $267.8 billion. The month’s AUM included market appreciation of $6.9 billion, net outflows of $1.4 billion and FX depreciation of $2.2 billion. LAZARD, INC. ASSETS UNDER MANAGEMENT (“AUM”) (unaudited) ($ in millions)     As of:   October 31, September 30,   20251 2025 Equity   $212,643 $208,510 Fixed Income   46,145 47,186 Other   8...
Back to Newsroom